Poniard (PARD) Puts Annual Meeting on Hold to Gain Support for Important Stock Split Proposal

Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), intends to adjourn its annual meeting of shareholders scheduled for Friday, July 8, 2011, until Friday, July 22, 2011, in order to solicit additional proxies to vote in favor of a proposal authorizing the Company's Board of Directors, in its discretion, to effect a reverse stock split in the range of 1-for-15 to 1-for-25.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Roper's (ROP) iPipeline Appoints Adam Boone as CFO
• Sportradar (SRAD) Appoints Craig Felenstein as CFO
• Oracle (ORCL) Introduces New AI Capabilities to Help Organizations Boost Sales